Chemistry is the key to drug discovery, but chemical data is stuck in the twentieth century. We’re generating precise chemical datasets purpose-built to propel drug discovery into the information age — and we’re doing it on a larger scale and faster than has ever before been possible. Terray Therapeutics is a biotechnology company led by pioneers and long-time leaders in artificial intelligence, synthetic (medicinal) chemistry, biology and preclinical development, automation, and nanotechnology. Chemical datasets generated using our novel ultra-dense microarray technology work seamlessly with our integrated machine learning and computational platform to systematically map biochemical interactions between small molecules and causes of disease. Iterative cycles of virtual molecular design and experimentation power AI and machine learning models, which in turn guide the next cycle of design. With a chemistry engine that measures billions of interactions daily and becomes increasingly precise with every cycle, we can answer an unprecedented array of questions — deriving insights that enable us to predictably create drugs for patients in need.
Location: United States, California, Pasadena
Employees: 11-50
Total raised: $180M
Founded date: 2018
Investors 4
| Date | Name | Website |
| - | XTX Ventur... | xtxmarkets... |
| 25.11.2021 | Digitalis ... | digitalisv... |
| 17.02.2022 | Madrona Ve... | madrona.co... |
| - | Two Sigma ... | twosigmave... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 22.10.2024 | Series B | $120M | - |
| 16.02.2022 | Series A | $60M | Madrona Ve... |
Mentions in press and media 8
| Date | Title | Description |
| 22.10.2024 | Terray Therapeutics: $120 Million (Series B) Secured To Improve Human Health | Terray Therapeutics, a biotechnology company focused on improving human health by transforming the speed, cost, and success rate of small molecule drug development using computation integrated with novel data at scale, announced Series B fu... |
| 17.10.2024 | Terray Therapeutics Closes $120M Series B Funding Round | Terray Therapeutics, a Los Angeles, CA-based biotechnology company improving human health by enhancing small molecule drug development, raised $120M in Series B funding. The round was led by Bedford Ridge Capital and existing investor NVent... |
| 26.06.2024 | From Pitch Meetings to Power Lunches: LA’s Exclusive Membership Clubs 🗝️ | Download the dot.LA App Summer's here, so it's time to zhuzh up your work environment. Discovering the best membership and social clubs in Los Angeles for meetings can boost networking and collaboration, offering exclusive venues and premiu... |
| 10.11.2023 | Terray Therapeutics Receives Investment from NVIDIA, et al | Terray Therapeutics, a Los Angeles, CA-based biotechnology company focused on small molecule drug discovery and development, received an investment from NVentures, NVIDIA’s venture capital arm. Additional financing included a syndicate of n... |
| 16.02.2022 | Terray Therapeutics Takes $60M For Chemical Data | Pasadena-based Terray Therapeutics, a startup developing chemical datasets aimed at use in AI-driven small molecule drug discovery, says it has raised $60M in its Series A funding round. The funding was led by Madrona Venture Group, and als... |
| 15.02.2022 | Terray Therapeutics Raises $60M in Series A Funding | Terray Therapeutics, a Pasadena, CA-based biotechnology company, raised $60M in Series A funding. The round was led by Madrona Venture Group with participation from Two Sigma Ventures, Digitalis Ventures, KdT Ventures, Goldcrest Capital, XT... |
| 15.02.2022 | Pasadena Biotech Terray Raises $60 Million to Speed Up Drug Discovery | After three years in stealth mode, a Pasadena biotech startup has emerged with $60 million and, it believes, a new way to create drugs. Terray Therapeutics launched on Tuesday with $60 million in Series A funding led by Madrona Venture Grou... |
| - | AI-biotech Terray emerges with $60M and a solution for data problems in drug R&D | Artificial intelligence-driven drug discovery can be like conducting an internet search. With each query, your search engine learns a bit more about you—information that shapes the next set of results, said Jacob Berlin, co-founder and CEO ... |